PCN163 - COST-EFFECTIVENESS OF ADD-ON PERTUZUMAB COMBINED WITH TRASTUZUMAB AND DOCETAXEL VERSUS PLACEBO AS TREATMENT OF HER-2 POSITIVE METASTATIC BREAST CANCER IN CZECH REPUBLIC
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.246
https://www.valueinhealthjournal.com/article/S1098-3015(18)33546-0/fulltext
Title :
PCN163 - COST-EFFECTIVENESS OF ADD-ON PERTUZUMAB COMBINED WITH TRASTUZUMAB AND DOCETAXEL VERSUS PLACEBO AS TREATMENT OF HER-2 POSITIVE METASTATIC BREAST CANCER IN CZECH REPUBLIC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33546-0&doi=10.1016/j.jval.2018.09.246
First page :
Section Title :
Open access? :
No
Section Order :
1783